Peijia Medical Limited
Peijia Medical Limited (HKSE: 9996) is trading at HK$4.81, about ₹59 at today's HKD/INR rate, as of 30 Sep 2026, 4:08 AM ET. Indian residents can buy Peijia Medical from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$4.63
Today's high
HK$4.85
52 week low
HK$3.73
52 week high
HK$7.37
9996 opened at HK$4.81, closed previously at HK$4.81, and has traded between HK$3.73 and HK$7.37 over the past 52 weeks.
About
Peijia Medical Limited specializes in the innovation and development of advanced medical devices for transcatheter valve therapies and neurointerventional procedures. Their extensive portfolio of transcatheter valve solutions includes numerous TAVR (transcatheter aortic valve replacement) systems, such as TaurusOne, the retrievable TaurusElite, TaurusNXT (a non-glutaraldehyde dry-tissue system), TaurusApex (featuring polymer leaflets), and Trilogy. For mitral valve interventions, they offer the HighLife transseptal replacement system, SpyderOne (a transapical TMVR system), Sutra for coaptation augmentation, and the GeminiOne edge-to-edge repair system. They also provide the MonarQ and Peijia systems for transcatheter tricuspid valve replacement. Complementary devices supporting these procedures include the TaurusAtlas transfemoral balloon catheter, TaurusExplora pre-shaped guidewire, and introducer sheaths. In the neurointerventional field, Peijia Medical develops devices like the Jasper and Presgo detachable coils (including the Jasper SS variant), various intracranial adjunctive stents such as NeuroStellar, and the SacSpeed balloon dilatation catheter. Additional offerings comprise the Tethys AS aspiration catheter, Syphonet stent retriever, Neway balloon microcatheter, Fluxcap balloon guiding catheter, Presgo microcatheters and micro guidewires, Heralder guiding and distal access catheters, the Tethys intermediate catheter, and the Jasper power supply. Furthermore, the company engages in trading activities. Peijia Medical Limited was founded in 2012 and is headquartered in Suzhou, People's Republic of China.
Key statistics
Avg. volume
909.49K
Market cap
HK$3.22B
P/E Ratio
-19.46
Price-to-sales ratio
3.51
Enterprise value
CN¥3.44B
Free cash flow yield
-9.06%
Debt-to-equity ratio
0.35
Return on equity
-11.02%
ROIC
-8.37%
Beta
0.62
Dividend yield
0.00%
Last dividend
HK$0.00
Financial overview
Revenue
CN¥712.87M
Earnings per share
-CN¥0.31
Free cash flow
-CN¥325.28M
Net profit margin
-17.98%
Gross margin
67.41%
EBITDA
-CN¥133.85M
Revenue growth
15.82%
Similar securities
This is not an investment recommendation
How to buy Peijia Medical from India
Indian residents can buy Peijia Medical shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Peijia Medical and place an order
Find Peijia Medical by name or by its ticker, 9996, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Peijia Medical trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Peijia Medical position in HKD and INR. Peijia Medical pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Peijia Medical from India
Trading and taxes when buying Peijia Medical from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NonePeijia Medical does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Peijia Medical stock?
Yes. Peijia Medical (9996) has been listed on the Hong Kong Stock Exchange since 2020, in the Medical - Devices industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Peijia Medical share cost in rupees?
One Peijia Medical share is HK$4.81 — about ₹59 at an HKD/INR rate of 12.24 on 29 Sep 2026. Both the Peijia Medical price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Peijia Medical from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Peijia Medical?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Peijia Medical shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Peijia Medical price. Paasa issues a capital-gains statement for your return.
Does Peijia Medical pay a dividend?
No. Peijia Medical does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Peijia Medical from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Peijia Medical a Hong Kong SAR China company, and does that change how it is taxed?
Peijia Medical trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Peijia Medical trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Peijia Medical shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Peijia Medical holding, its cost and its closing value.
How do I sell Peijia Medical and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.